EA201300096A1 - Лекарственный препарат, обладающий антибактериальным, противоязвенным и иммуномодулирующим действием - Google Patents

Лекарственный препарат, обладающий антибактериальным, противоязвенным и иммуномодулирующим действием

Info

Publication number
EA201300096A1
EA201300096A1 EA201300096A EA201300096A EA201300096A1 EA 201300096 A1 EA201300096 A1 EA 201300096A1 EA 201300096 A EA201300096 A EA 201300096A EA 201300096 A EA201300096 A EA 201300096A EA 201300096 A1 EA201300096 A1 EA 201300096A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibacterial
drugs
contracting
immune model
drug
Prior art date
Application number
EA201300096A
Other languages
English (en)
Other versions
EA021496B1 (ru
Inventor
Шокан Сабирханович БЕГАЛИЕВ
Кульшат Магзумовна НУГЕРБЕКОВА
Original Assignee
Шокан Сабирханович БЕГАЛИЕВ
Кульшат Магзумовна НУГЕРБЕКОВА
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шокан Сабирханович БЕГАЛИЕВ, Кульшат Магзумовна НУГЕРБЕКОВА filed Critical Шокан Сабирханович БЕГАЛИЕВ
Publication of EA201300096A1 publication Critical patent/EA201300096A1/ru
Publication of EA021496B1 publication Critical patent/EA021496B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12—Iodine, e.g. iodophors; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области медицины, в частности к лекарственным препаратам антибактериального, противоязвенного и иммуномодулирующего действия, которые могут быть использованы в инъекционной форме. Лекарственный препарат содержит компоненты при следующем их соотношении (мас.%):Фармацевтически эффективное количество препарата вводят внутривенно, внутримышечно или перорально.
EA201300096A 2011-05-16 2011-11-10 Лекарственный препарат, обладающий противовирусным и антибактериальным действием EA021496B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KZ20110501 2011-05-16
PCT/KZ2011/000018 WO2012158002A1 (ru) 2011-05-16 2011-11-10 Лекарственный препарат «renessans», обладающий антибактериальным, противоязвенным и иммуномодулирующим действием

Publications (2)

Publication Number Publication Date
EA201300096A1 true EA201300096A1 (ru) 2013-08-30
EA021496B1 EA021496B1 (ru) 2015-06-30

Family

ID=47177155

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300096A EA021496B1 (ru) 2011-05-16 2011-11-10 Лекарственный препарат, обладающий противовирусным и антибактериальным действием

Country Status (7)

Country Link
US (1) US20140072598A1 (ru)
EP (1) EP2606885B1 (ru)
JP (1) JP2014513721A (ru)
KR (1) KR20140033123A (ru)
CN (1) CN103561735B (ru)
EA (1) EA021496B1 (ru)
WO (1) WO2012158002A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019045597A1 (ru) * 2017-08-28 2019-03-07 Олег Виктрович ГРАЧЕВ Композиция для лечения заболеваний вирусной и кокковой этиологии

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974776B (zh) * 2019-11-22 2023-02-28 东南大学 一种碘-淀粉气凝胶及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
US5545401A (en) 1994-06-02 1996-08-13 Shanbrom; Edward Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine
KZ6730B (ru) * 1996-01-26 1998-11-16
JPH10109938A (ja) 1996-08-15 1998-04-28 Aikusu Lab Sangyo:Kk Ｈｉｖ，クラミジア，淋菌，トリポネマパリヅム及び単純性ヘルペス等のｓｔｄ感染予防剤並びにこの感染予防剤における主剤と基剤との保存混合装置
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
KR20010083057A (ko) * 1998-06-19 2001-08-31 추후제출 항-감염 및 피임성을 갖는 의료 장치
WO2001078751A1 (en) * 2000-04-17 2001-10-25 'armenicum+' Jsc Antiviral and antibacterial pharmaceutical preparation 'armenicum' and its use for treatment of infectious diseases
US20030211173A1 (en) * 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
KZ13765A (ru) * 2002-12-03 2003-12-15

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019045597A1 (ru) * 2017-08-28 2019-03-07 Олег Виктрович ГРАЧЕВ Композиция для лечения заболеваний вирусной и кокковой этиологии

Also Published As

Publication number Publication date
CN103561735A (zh) 2014-02-05
EP2606885B1 (en) 2016-05-11
JP2014513721A (ja) 2014-06-05
US20140072598A1 (en) 2014-03-13
EA021496B1 (ru) 2015-06-30
CN103561735B (zh) 2016-01-20
EP2606885A1 (en) 2013-06-26
KR20140033123A (ko) 2014-03-17
WO2012158002A1 (ru) 2012-11-22
EP2606885A4 (en) 2013-07-24

Similar Documents

Publication Publication Date Title
MD4736B1 (ru) Полициклическое соединение карбамоилпиридона и его фармацевтическое применение
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
EA201692443A1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
JP2015517488A5 (ru)
EA201590862A1 (ru) Фармацевтические композиции
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
AR101674A1 (es) Uso de un compuesto tricíclico que contiene nitrógeno
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
EA201291410A1 (ru) Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат
MX2013003635A (es) Compuestos de n-heteroarilo.
PH12015502406A1 (en) Orally administrable pharmaceutical composition for prevention or treatment of dry eye syndrome, comprising rebamipide or prodrug thereof
UA111599C2 (uk) Композиція каспофунгіну
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
GT201300278A (es) Inducción de tolerancia inmunológica utilizando metotrexato
EA201590191A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и фампридина
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
MX2016007682A (es) Composicion farmaceutica que comprende ivabradina amorfa.
RU2016109085A (ru) Применение иммунорегуляторного белка ганодерма (rlz-8) в получении лекарственного средства для лечения меланомы
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
EA201300096A1 (ru) Лекарственный препарат, обладающий антибактериальным, противоязвенным и иммуномодулирующим действием
BR112015013223A2 (pt) composição farmacêutica
EA201590415A1 (ru) Производные диазепинона, применимые для лечения синдрома хрупкой х-хромосомы, болезни паркинсона или рефлюксного заболевания

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU